Metagenomi, Inc. Common Stock
General ticker "MGX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $81.0M (TTM average)
Metagenomi, Inc. Common Stock follows the US Stock Market performance with the rate: 20.8%.
Estimated limits based on current volatility of 2.6%: low 1.64$, high 1.74$
Factors to consider:
- Total employees count: 236 as of 2023
Short-term MGX quotes
Long-term MGX plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $17.20MM | $44.76MM | $52.30MM |
| Operating Expenses | $61.84MM | $123.25MM | $141.20MM |
| Operating Income | $-44.64MM | $-78.49MM | $-88.90MM |
| Non-Operating Income | $3.62MM | $18.26MM | $5.33MM |
| Interest Expense | $0.10MM | $0.00MM | $0.00MM |
| R&D Expense | $43.14MM | $94.40MM | $109.18MM |
| Income(Loss) | $-41.02MM | $-60.23MM | $-83.57MM |
| Taxes | $2.57MM | $8.03MM | $-5.51MM |
| Profit(Loss)* | $-43.59MM | $-68.25MM | $-78.06MM |
| Stockholders Equity | $-74.43MM | $215.17MM | $234.86MM |
| Assets | $414.49MM | $364.84MM | $324.60MM |
| Operating Cash Flow | $29.72MM | $-91.41MM | $-109.07MM |
| Capital expenditure | $13.98MM | $9.81MM | $3.11MM |
| Investing Cash Flow | $-122.20MM | $45.73MM | $-88.16MM |
| Financing Cash Flow | $239.59MM | $1.01MM | $84.01MM |
| Earnings Per Share** | $-1.16 | $-1.82 | $-2.09 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.